NIH Covid-19 Treatment Guidelines
COVID-19 Treatment Guidelines
What's new in Guidlines
Last updated : July 17,2020 by NIH
Remdesivir:
It is recommened that remdesivir for use in hospitalized patients with COVID-19 who requires supplemental Oxyzen but who are not mechanically ventilated or on extracorporeal membrane oxygenation(BI).
Corticosteroids(Including Dexamethasone):
Dexamethasone is used in patients who are mechanically ventilated and in patients who require supplemental oxygen but who are not mechanically ventilated.
New sections of the Guidlines- No change to the panel's recommendations or ongoing clinical trials for treatment of Covid-19
Adjuntive Therapy like Vitamin C,Vitamin D and Zinc Supplementation
Prevention and Prophylaxis of SARS-CoV-2 Infection
Hydroxychloroquin plus Azithromycin
Blood-Derived products like convalescent plasma
Immunomodulators like Alfa and Beta interferons
Kinase inhibitors- Like Janus Kinase(JAK) inhibitors and Bruton's tyrosine Kinase (BTK) inhibitors
Lopinavir/Ritonavir and other HIV protease Inhibitors.